D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Liberty Media Series C
FWONK
|
+$422M |
| 2 |
Alibaba
BABA
|
+$360M |
| 3 |
HP
HPQ
|
+$296M |
| 4 |
Pfizer
PFE
|
+$258M |
| 5 |
Gilead Sciences
GILD
|
+$242M |
Top Sells
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$602M |
| 2 |
AbbVie
ABBV
|
+$324M |
| 3 |
Liberty Media Series A
FWONA
|
+$314M |
| 4 |
GE Aerospace
GE
|
+$229M |
| 5 |
SNDK
SANDISK CORP
SNDK
|
+$183M |
Sector Composition
| 1 | Technology | 13.85% |
| 2 | Consumer Discretionary | 12.91% |
| 3 | Energy | 12.08% |
| 4 | Healthcare | 10.56% |
| 5 | Communication Services | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Genpact
G
$7.71B
| $26.2M | 0.03% |
1,607,239
-186,371
| -10% | -$3.04M |
|
352
Graham Holdings Company
GHC
$4.93B
| $26.1M | 0.03% |
61,695
+3,840
| +7% | +$1.62M |
|
353
Patterson-UTI
PTEN
$2.16B
| $26.1M | 0.03% |
801,493
+161,157
| +25% | +$5.24M |
|
354
Stellus Capital Investment Corp
SCM
$427M
| $26M | 0.03% |
1,875,058
-800
| -0% | -$11.1K |
|
355
Abbott
ABT
$230B
| $25.8M | 0.03% |
620,408
-637,512
| -51% | -$26.5M |
|
356
Fiserv
FI
$73.5B
| $25.7M | 0.03% |
795,732
-775,770
| -49% | -$25.1M |
|
357
Chevron
CVX
$310B
| $25.5M | 0.03% |
213,821
+156,969
| +276% | +$18.7M |
|
358
Check Point Software Technologies
CHKP
$20.7B
| $25.3M | 0.03% |
365,682
+297,580
| +437% | +$20.6M |
|
359
Bristol-Myers Squibb
BMY
$95.1B
| $25.3M | 0.03% |
493,609
-684,944
| -58% | -$35.1M |
|
360
Fortinet
FTNT
$61.6B
| $25.2M | 0.03% |
4,980,195
-1,654,865
| -25% | -$8.36M |
|
361
Arch Capital
ACGL
$33.9B
| $25M | 0.03% |
1,368,612
+665,544
| +95% | +$12.1M |
|
362
Treehouse Foods
THS
$905M
| $25M | 0.03% |
309,961
+163,812
| +112% | +$13.2M |
|
|
FNFV
363
DELISTED
Fidelity Natl Financial, Inc.
FNFV
| $24.8M | 0.03% |
+2,360,864
| New | +$24.8M |
|
|
WFM
364
DELISTED
Whole Foods Market Inc
WFM
| $24.6M | 0.03% |
646,626
+197,579
| +44% | +$7.53M |
|
365
GSK
GSK
$80.6B
| $24.6M | 0.03% |
+428,783
| New | +$24.6M |
|
366
Viatris
VTRS
$12.2B
| $24.6M | 0.03% |
541,553
+301,025
| +125% | +$13.7M |
|
367
Schlumberger
SLB
$53.4B
| $24.6M | 0.03% |
241,457
-41,094
| -15% | -$4.18M |
|
368
Nokia
NOK
$24.7B
| $24.5M | 0.03% |
2,896,846
+273,801
| +10% | +$2.32M |
|
369
Teleflex
TFX
$5.75B
| $24.5M | 0.03% |
233,121
-6,683
| -3% | -$702K |
|
|
WBMD
370
DELISTED
WebMD Health Corp.
WBMD
| $24.4M | 0.03% |
584,503
+168,760
| +41% | +$7.06M |
|
|
OWW
371
DELISTED
ORBITZ WORLDWIDE, INC
OWW
| $24.4M | 0.03% |
3,104,423
+1,001,279
| +48% | +$7.88M |
|
|
CNVR
372
DELISTED
CONVERSANT INC COM STK (DE)
CNVR
| $24.4M | 0.03% |
712,851
+159,916
| +29% | +$5.48M |
|
|
AVP
373
DELISTED
Avon Products, Inc.
AVP
| $24.3M | 0.03% |
1,927,212
+657,621
| +52% | +$8.29M |
|
|
JCP
374
DELISTED
J.C. Penney Company, Inc.
JCP
| $24.2M | 0.03% |
2,414,124
+2,352,026
| +3,788% | +$23.6M |
|
375
Goodyear
GT
$2.46B
| $24.1M | 0.03% |
1,069,252
-1,276,094
| -54% | -$28.8M |
|